Patupilone Activity in Advanced/Metastatic Hepatocellular Carcinoma
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety, efficacy, and activity of patupilone in patients with
advanced unresectable and/or metastatic hepatocellular carcinoma based on tumor response
using modified RECIST criteria.